[New] Accelerating Medical Research:AI technologies are speeding up drug discovery and clinical trials, with the Medical Research Future Fund's $1.4 billion investment over 13 years expected to reduce research timelines by 35%.
Journal
[New] The integration of large-scale physics simulations with generative AI promises transformative applications in materials science and drug discovery by early 2026.
AGI Agent
[New] 43% of respondents expect overall investment to increase in 2026, led by antibody-drug conjugates, cell and gene therapies, and GLP-1 manufacturing.
Engineering News-Record
[New] By distribution channel, the online drug stores segment is projected to grow at a CAGR of 5.51% between 2025 and 2034.
Precedence Research
[New] The World Health Organization sounded the alarm about a growing threat of drug-resistant bacteria around the globe that could undermine life-saving treatments.
MM+M - Medical Marketing and Media
[New] Novartis expects billions in peak sales for a newer complement system-targeting drug, Fabhalta.
BioPharma Dive
[New] Novo invested $220 million in Denmark to build a raw materials plant scheduled 2027, as chronic-disease drug demand rises.
IntuitionLabs
[New] In 2024-2025, a surge of new pharmaceutical manufacturing facilities has been initiated worldwide, as major drug makers respond to supply-chain vulnerabilities, government incentives, and growing demand for cutting-edge therapies.
IntuitionLabs
[New] Takeda has now shifted its priority to six drug candidates, including elritercept for anaemia in blood cancers, which is being tested in late-stage trials and is expected to bring in an estimated combined peak sales of $10 billion to $20 billion.
pharmexec
[New] Alice & Bob's demonstration that useful quantum chemistry simulations require 27 times fewer qubits than previously thought means applications in drug discovery and sustainable agriculture could arrive years earlier than expected.
Our Haven: Tech
Last updated: 21 October 2025
Hi,
Would you like a quick online demo of our service from an experienced member of our team?